Saved in:
| Hovedforfatter: | |
|---|---|
| Format: | Recurso digital |
| Sprog: | |
| Udgivet: |
Zenodo
2025
|
| Fag: | |
| Online adgang: | https://doi.org/10.5281/zenodo.14652014 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|
Indholdsfortegnelse:
- <p><span>In the practice of medicine, biomarkers have become extremely valuable from a scientific and clinical standpoint. Biomarkers have the potential to be helpful at every stage of the disease process. Markers could be utilized for risk assessment and screening prior to diagnosis. Markers can be used to decide on initial therapy selection, staging, and grading during diagnosis. They can be used to track recurrent disorders, choose further therapies, or monitor therapy throughout treatment. Numerous prospective biomarkers with potential clinical utility have been produced by developments in molecular pathology, proteomics, and genomics. In order to accomplish “personalization” of therapy and illness prevention, biomarkers discovered through the use of new high-throughput technologies will need to be incorporated into medical practice</span><span>.</span></p>